Intravitreal injection of octreotide acetate

Journal of Ocular Pharmacology and Therapeutics

Volumn 13, Issue 2, 1997, Pages 171-177

  Robertson, Joseph E ^a,f   Westra, Igor ^b   Woltering, Eugene A ^c   Winthrop, Kevin L ^a   Barrie, Rosemary ^a   O'Dorisio, Thomas M ^d   Holmes, Douglas ^e  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b Carolina Eye Association ^*  (United States)

^c LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e UNIVERSITY OF COLORADO   (United States)

^f CASEY EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OCTREOTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAT; CATARACT; DRUG ELIMINATION; EYE DISEASE; INTRAVITREAL DRUG ADMINISTRATION; IRIS RUBEOSIS; NONHUMAN; RABBIT; RADIOIMMUNOASSAY; RETINA NEOVASCULARIZATION; RETROLENTAL FIBROPLASIA; VITREOUS BODY;

EID: 0030980153     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.1997.13.171     Document Type: Article

References (19)

1. Gibson, D.L., Sheps SB, Uh S.H., Schechter, M.T., and McCormick, A.Q. Retinopathy of prematurity-induced blindness: birth weight-specific survival and the new epidemic. Pediatrics, 86:405-412, 1990.
2. Diabetic Retinopathy. Basic and Clinical Science Course. American Academy of Ophthalmology. Section 12: 51-63, 1995-96.
3. Reichlin, S. Somatostatin. N. Engl. J. Med., 309:1495-1501, 1983.
4. Woltering, E.A., Barrie, R., O'Dorisio, T.M., Arce, D., Ure, T., Cramer, A., Holmes, D., Robertson, J., and Fassler, J. Somatostatin analogues inhibit angiogenesis in the chick chorioallantoic membrane. J. Surg. Res., 50:245-251, 1991.
5. Patel, P.C., Barrie, R., Hill, N., Landeck, S., Kurozawa, D., and Woltering, E.A. Postreceptor signal transduction mechanisms involved in octreotide-induced inhibition of angiogenesis. Surgery, 116:1148-1152, 1994.
6. McCombe, M., Lightman , S., Ecklund, D.J., Hamilton, A.M., and Lightman, S.L. Effect of a long-acting Somatostatin analogue (BIM23014) on proliferative diabetic retinopathy: a pilot study. Eye, 5:569-575, 1991.
7. Grant, M., Russell, B., Fitzgerald, C., and Merimee, T.J. Insulin-like growth factors in vitreous: studies in control and diabetic subjects with neovascularization. Diabetes, 35:416-420, 1986.
8. Frank, R.N., Hoffman, W.H., Podgor, M.J., Joondeph, H.C., Lewis, R.A., Margherio, R.R., Nachazel, D.P., Weiss, H., Christopherson, K.W., and Cronin, M.A. Retinopathy in juvenile-onset diabetes of short duration. Ophthalmology, 87:1-9, 1980.
9. Merimee, T.J. A follow-up study of vascular disease in growth-hormone-deficient dwarfs with diabetes. N. Engl. J. Med., 298:1217-1222, 1978.
10. Kohner, E.M., Joplin, G.F., Blach, R.K., Cheng, H., and Fraser, T.R. Pituitary ablation in the treatment of diabetic retinopathy: a randomized trial. Trans. Ophthalmol. Soc. UK, 92:79-90, 1972.
11. Melmed, S. Octreotide stimulates insulin-like growth factor protein-I: A novel mechanism of drug action on acromegaly. Semin. Oncol., 21 (suppl. 13):65-69, 1994.
12. Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy: clinical application of Diabetic Retinopathy Study (DRS) findings, DRS report no. 8. Ophthalmology, 88:583-600, 1981.
13. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity. Arch. Ophthalmol., 106:471-479, 1988.
14. Benson, W.E., Brown, G.C., and Tasman, W. Diabetes and its Ocular Complications. W.B. Saunders, Philadelphia, 1988, p. 144-153.
15. Grant, M.B. and Caballero, S. Inhibition of human retinal endothelial cell (HREC) proliferation by the Somatostatin analogue, octreotide [abstract]. Invest. Ophthalmol., 34:900, 1993.
16. O'Dorisio, T.M., Gaginella, T.S., O'Dorisio, M.S., Meleca, R.W., Wray, D.A., and Osei, K. Sandostatin: Assay and Efficacy in VIPoma and Insulinoma. In: Sandostatin in the Treatment of GEP Endocrine Tumors. Springer-Verlag, New York, 1989, p. 43-48.
17. Shapiro, B., Pienta, K., Heldsinger, A., and Vinik, A.L. Somatostatin is an agonist and non-competitive antagonist of gastrin in oxyntic cell function. Endocrinology, 109:1117-1121, 1981.
18. Dharmsathaphorn, K., Binder, H.J., and Dobbins, J.W. Somatostatin stimulates sodium and chloride absorption in the rabbit ileum. Gastroenterology, 78:1559-1565, 1980.
19. Setyono-Han, B., Henkelman, M.S., Foekens, J.A., and Klijn, J.G.M. Direct inhibitory effects of somatostatin (analogues) on the growth of human breast cancer cells. Cancer Res. 47:1566-1570, 1987.